首页> 外文学位 >Quantitative histomorphometry of digital pathology as a companion diagnostic: Predicting outcome for ER+ breast cancers.
【24h】

Quantitative histomorphometry of digital pathology as a companion diagnostic: Predicting outcome for ER+ breast cancers.

机译:数字病理的定量组织形态计量学作为辅助诊断:预测ER +乳腺癌的结局。

获取原文
获取原文并翻译 | 示例

摘要

This work involves the creation of an image-based companion diagnostic framework that employs quantitative features extracted from whole-slide, H & E stained digital pathology (DP) images to distinguish patients based on disease outcome, with a clinical application aimed at distinguishing estrogen receptor-positive (ER+) breast cancer (BCa) patients with good and poor outcomes. Quantitative histomorphometry (QH) -- the conversion of a digitized histopathology slide into a series of quantitative measurements of tumor morphology -- is a rapidly growing field aimed at introducing advanced image analytics into the histopathological workflow. The thrust towards personalized medicine has led to the development of companion diagnostic tools that measure gene expression, yielding quantitative outcome predictions for improved disease stratification and customized therapies, e.g. Oncotype DX (Genomic Health, Inc.) for ER+ BCa. Yet, tumor morphology is often correlated with genomic assays, suggesting that genotypic variations in biologically distinct classes of tumors lead to distinct patterns of tumor cell morphology and tissue architecture in histopathology.;The application of this work to ER+ BCa is highly relevant to current clinical needs. Current treatment guidelines recommend that the majority of women with ER+ BCa receive chemotherapy in addition to hormonal therapy; yet, approximately half will not benefit from chemotherapy while still enduring its harmful side effects. Hence, there is a clear need for the development of automated prognostic tools to identify women with poorer outcomes who will likely benefit from chemotherapy.;The primary novel contributions of this work are (1) a color standardization system for improving the consistency in appearance of tissue structures across images, (2) the identification of tissue structures and corresponding QH signatures with prognostic value in ER+ BCa, (3) a multi-field-of-view framework for robust integration of prognostic information across whole-slide DP images, and (4) a method for predicting classifier performance for a large data cohort based on the availability of limited training data. This work will pave the way for the development of novel companion diagnostic systems capable of producing quantitative and reproducible image-based risk scores. These risk scores will play a vital role in decision support by helping clinicians predict patient outcome and prescribing appropriate therapies.
机译:这项工作涉及创建基于图像的伴随诊断框架,该框架利用从全幻灯片,H&E染色的数字病理学(DP)图像中提取的定量特征来根据疾病结果区分患者,并将其临床应用旨在区分雌激素受体阳性和阴性的乳腺癌(BC +)患者。量化组织形态计量学(QH)-将数字化组织病理学切片转换为一系列肿瘤形态学定量测量-是一个快速发展的领域,旨在将高级图像分析引入组织病理学工作流程中。个性化医学的推动力导致了可测量基因表达的伴随诊断工具的开发,可产生定量结果预测以改善疾病分层和定制疗法,例如ER + BCa的Oncotype DX(Genomic Health,Inc.)。然而,肿瘤形态学常常与基因组测定相关,这表明生物学上不同类别的肿瘤的基因型变异导致组织病理学中肿瘤细胞形态学和组织结构的不同模式。;这项工作在ER + BCa中的应用与当前临床高度相关。需要。当前的治疗指南建议,大多数ER + BCa女性除激素治疗外还接受化学疗法。然而,大约一半将无法从化学疗法中受益,同时仍会承受其有害的副作用。因此,显然需要开发自动的预后工具来识别预后较差的女性,这些女性可能会从化疗中受益。这项工作的主要新贡献是(1)一种用于改善皮肤外观一致性的颜色标准化系统。跨图像的组织结构,(2)识别具有ER + BCa预后价值的组织结构和相应的QH签名,(3)多视野框架,用于在整个幻灯片DP图像之间可靠地集成预后信息,以及(4)一种基于有限训练数据的可用性预测大数据队列分类器性能的方法。这项工作将为开发能够产生定量和可再现的基于图像的风险评分的新型伴随诊断系统铺平道路。这些风险评分将通过帮助临床医生预测患者预后并制定适当的治疗方法,在决策支持中发挥至关重要的作用。

著录项

  • 作者

    Basavanhally, Ajay Nagesh.;

  • 作者单位

    Rutgers The State University of New Jersey - New Brunswick.;

  • 授予单位 Rutgers The State University of New Jersey - New Brunswick.;
  • 学科 Engineering Biomedical.;Health Sciences Oncology.;Health Sciences Pathology.
  • 学位 Ph.D.
  • 年度 2014
  • 页码 150 p.
  • 总页数 150
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号